- Home
- ABR vs CLDX Comparison
ABR vs CLDX Comparison
Compare ABR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABR
- CLDX
- Stock Information
- Founded
- ABR 2003
- CLDX 1983
- Country
- ABR United States
- CLDX United States
- Employees
- ABR N/A
- CLDX N/A
- Industry
- ABR Real Estate Investment Trusts
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ABR Real Estate
- CLDX Health Care
- Exchange
- ABR Nasdaq
- CLDX Nasdaq
- Market Cap
- ABR 2.7B
- CLDX 2.9B
- IPO Year
- ABR 2004
- CLDX 2008
- Fundamental
- Price
- ABR $14.51
- CLDX $26.53
- Analyst Decision
- ABR Hold
- CLDX Buy
- Analyst Count
- ABR 6
- CLDX 8
- Target Price
- ABR $14.25
- CLDX $64.83
- AVG Volume (30 Days)
- ABR 2.5M
- CLDX 1.1M
- Earning Date
- ABR 11-01-2024
- CLDX 11-06-2024
- Dividend Yield
- ABR 11.80%
- CLDX N/A
- EPS Growth
- ABR N/A
- CLDX N/A
- EPS
- ABR 1.35
- CLDX N/A
- Revenue
- ABR $650,354,000.00
- CLDX $9,976,000.00
- Revenue This Year
- ABR N/A
- CLDX N/A
- Revenue Next Year
- ABR N/A
- CLDX N/A
- P/E Ratio
- ABR $10.80
- CLDX N/A
- Revenue Growth
- ABR N/A
- CLDX 128.55
- 52 Week Low
- ABR $11.77
- CLDX $22.93
- 52 Week High
- ABR $16.35
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- ABR 41.61
- CLDX 46.52
- Support Level
- ABR $14.37
- CLDX $22.93
- Resistance Level
- ABR $14.90
- CLDX $26.78
- Average True Range (ATR)
- ABR 0.40
- CLDX 1.60
- MACD
- ABR -0.08
- CLDX 0.30
- Stochastic Oscillator
- ABR 16.19
- CLDX 68.39
About ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.